Company news
Theravance Biopharma, Inc. news in 2023
Theravance Biopharma, Inc.'s news releases, calls and decks from 2023, newest first.
Theravance Biopharma, Inc. Announces Appointment of Jeremy Grant to Board of Directors
December 20, 2023
Theravance Biopharma to Conduct Investor Meetings During the J.P. Morgan 42nd Annual Healthcare Conference
December 17, 2023
Theravance Biopharma to Present New Ampreloxetine Data at the 34th International Symposium on The Autonomic Nervous System
November 15, 2023
Theravance Biopharma to Participate in the 6th Annual Evercore ISI HealthCONx Conference
November 14, 2023
Viatris and Theravance Biopharma Announce Positive Top-Line Results from YUPELRI® (revefenacin) Phase III Trial in China for the Treatment of Chronic Obstructive Pulmonary Disease (COPD)
November 12, 2023
Theravance Biopharma, Inc. Reports Third Quarter 2023 Financial Results and Provides Business Update
November 6, 2023
Theravance Biopharma to Report Third Quarter 2023 Financial Results on November 7, 2023
October 18, 2023
Theravance Biopharma to Present New Ampreloxetine Data at the 2023 International Congress of Parkinson's Disease and Movement Disorders
August 27, 2023
Theravance Biopharma, Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update
August 6, 2023
Theravance Biopharma to Report Second Quarter 2023 Financial Results on August 7, 2023
July 23, 2023
Theravance Biopharma, Inc. Announces Orphan Drug Designation Granted to Ampreloxetine for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients with Multiple System Atrophy
May 8, 2023
Theravance Biopharma, Inc. Reports First Quarter 2023 Financial Results and Provides Business Update
May 7, 2023
Theravance Biopharma to Report First Quarter 2023 Financial Results on May 8, 2023
April 23, 2023
Theravance Biopharma, Inc. Announces Appointment of Jim Kelly, Managing Director at Weiss Asset Management, to Board of Directors
April 10, 2023
Theravance Biopharma, Inc. Announces Strategic Actions and Reports Fourth Quarter / Full Year 2022 Financial Results and Business Update
February 26, 2023
Theravance Biopharma to Report Fourth Quarter and Full Year 2022 Financial Results on February 27, 2023
February 20, 2023
Theravance Biopharma, Inc. Highlights 2022 Accomplishments and 2023 Key Targets
January 8, 2023
Calls in 2023
- Theravance Biopharma (NASDAQ:TBPH) Q3 2023 Earnings Call
Nov 7, 2023
Transcript - Theravance Biopharma (NASDAQ:TBPH) Q2 2023 Earnings Call
Aug 7, 2023
Transcript - Theravance Biopharma (NASDAQ:TBPH) Q1 2023 Earnings Call
May 8, 2023
Transcript - Theravance Biopharma (NASDAQ:TBPH) Q4 2022 Earnings Call
Feb 27, 2023
Transcript
Decks in 2023
- Q3 2023 Earnings Presentation
Earnings · 39 slides · Nov 7, 2023
- Investor Presentation (September 2023)
Investor deck · 38 slides · Sep 12, 2023
- Q2 2023 Earnings Presentation
Earnings · 35 slides · Aug 7, 2023
- Q1 2023 Earnings Presentation
Earnings · 41 slides · May 8, 2023
- 22nd Annual Needham Virtual Healthcare Conference 2023
Conference · 32 slides · Apr 17, 2023
- FY2022 Earnings Presentation
Earnings · 31 slides · Feb 27, 2023
- Investor Presentation (January 2023)
Investor deck · 27 slides · Jan 9, 2023